Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be

Dexcom stock was soaring after its stellar earnings revealed that the naked of “continuous glucose monitoring devices” has not been hurt by the adoption of Ozempic—and might never be.

The company provided early evidence for that thesis is in the early stages of playing out with its third-quarter results. Sales grew 26% year over year to $975 million, above estimates of $940 million, while profit margins expanded faster-than-expected, translating to earnings of $0.50, which surpassed forecasts for $0.34.

The best news of all—and perhaps the key nugget of information—is that Dexcom said it sees evidence that GLP-1s are indeed helping demand for CGMs. On the earnings call, management said that doctors are prescribing CGMs at a faster clip for patients that are starting GLP-1s such as Ozempic, showing that the device is acting as a complementary product for the treatments.

Australia Australia Latest News, Australia Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stock of Hoka sneaker maker Deckers soars 10% on earnings beatClaudia Assis is a San Francisco-based reporter for MarketWatch. Follow her on Twitter ClaudiaAssisMW.
Source: MarketWatch - 🏆 3. / 97 Read more »

Intel Stock Earnings: INTC rises nearly 10% on earnings surprise, robust Q4 outlookIntel (INTC) stock soared 9.7% mid-session on Friday after the legacy semiconductor company posted earnings nearly double Wall Street’s expectation.
Source: FXStreetNews - 🏆 14. / 72 Read more »

Stock Market News Today: Dow Opens Higher, Meta Stock Price Falls; Amazon Earnings in FocusLive updates on what's moving markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.
Source: WSJ - 🏆 98. / 63 Read more »

Stock Market News Today: Nasdaq Falls 300 Points; Alphabet Stock Price Falls After EarningsLive updates on what's moving markets, including stocks the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite
Source: WSJ - 🏆 98. / 63 Read more »

Glucose monitor maker DexCom’s stock soars after big earnings beat, raised revenue outlook as real-time monitoring awareness growsTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Source: MarketWatch - 🏆 3. / 97 Read more »